Current management of portal hypertension

被引:192
作者
Bosch, J
Abraldes, JG
Groszmann, R
机构
[1] Univ Barcelona, IDIBAPS, Hosp Clin, IMD,Liver Unit,Hepat Hemodynam Lab, E-08036 Barcelona, Spain
[2] Yale Univ, Sch Med, VA Med Ctr, Hepat Hemodynam Lab, New Haven, CT USA
[3] W Haven Univ, VA Med Ctr, Hepat Hemodynam Lab, New Haven, CT USA
关键词
D O I
10.1016/S0168-8278(02)00430-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S54 / S68
页数:15
相关论文
共 183 条
  • [1] Propranolol for the prevention of first esophageal variceal hemorrhage:: A lifetime commitment?
    Abraczinskas, DR
    Ookubo, R
    Grace, ND
    Groszmann, RJ
    Bosch, J
    Garcia-Tsao, G
    Richardson, CR
    Matloff, DS
    Rodés, J
    Conn, HO
    [J]. HEPATOLOGY, 2001, 34 (06) : 1096 - 1102
  • [2] Somatostatin and analogues in portal hypertension
    Abraldes, JG
    Bosch, J
    [J]. HEPATOLOGY, 2002, 35 (06) : 1305 - 1312
  • [3] Combination of endoscopic variceal ligation and propranolol with endoscopic variceal ligation alone in the prevention of first variceal bleed: An interim analysis
    Agrawal, SR
    Singh, J
    Sharma, S
    Sarin, SK
    [J]. JOURNAL OF HEPATOLOGY, 2002, 36 : 197 - 197
  • [4] HEMODYNAMIC-EFFECTS OF ALPHA-ADRENERGIC BLOCKADE WITH PRAZOSIN IN CIRRHOTIC-PATIENTS WITH PORTAL-HYPERTENSION
    ALBILLOS, A
    LLEDO, JL
    BANARES, R
    ROSSI, I
    IBORRA, J
    CALLEJA, JL
    GARRIDO, A
    ESCARTIN, P
    BOSCH, J
    [J]. HEPATOLOGY, 1994, 20 (03) : 611 - 617
  • [5] CONTINUOUS PRAZOSIN ADMINISTRATION IN CIRRHOTIC-PATIENTS - EFFECTS ON PORTAL HEMODYNAMICS AND ON LIVER AND RENAL-FUNCTION
    ALBILLOS, A
    LLEDO, JL
    ROSSI, I
    PEREZPARAMO, M
    TABUENCA, MJ
    BANARES, R
    IBORRA, J
    GARRIDO, A
    ESCARTIN, P
    BOSCH, J
    [J]. GASTROENTEROLOGY, 1995, 109 (04) : 1257 - 1265
  • [6] Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension
    Albillos, A
    García-Pagán, JC
    Iborra, J
    Bandi, JC
    Cacho, G
    Pérez-Paramo, M
    Escorsell, A
    Calleja, JL
    Escartin, P
    Bosch, J
    [J]. GASTROENTEROLOGY, 1998, 115 (01) : 116 - 123
  • [7] Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide
    Angeli, P
    Volpin, R
    Gerunda, G
    Craighero, R
    Rone, P
    Merenda, R
    Amodio, P
    Sticca, A
    Caregaro, L
    Maffei-Faccioli, A
    Gatta, A
    [J]. HEPATOLOGY, 1999, 29 (06) : 1690 - 1697
  • [8] Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis
    Angelico, M
    Carli, L
    Piat, C
    Gentile, S
    Capocaccia, L
    [J]. GASTROENTEROLOGY, 1997, 113 (05) : 1632 - 1639
  • [9] Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European acute bleeding oesophageal variceal episodes (ABOVE) randomised trial
    Avgerinos, A
    Nevens, F
    Raptis, S
    Fevery, J
    Armonis, A
    Manolakopoulos, S
    Poulianos, G
    Tzathas, C
    Katsaros, D
    Soutos, D
    Zacharopoulose, A
    Adler, M
    Bourgeois, N
    Bac, DJ
    VanBuuren, HR
    Decruyenaere, J
    Elewaut, A
    Deman, M
    Lepoutre, L
    VanderSpek, P
    Hautekeete, M
    Reynaert, H
    Buyse, M
    Ritter, L
    Burtin, B
    Darcis, T
    Ioannou, J
    Natens, J
    Natens, O
    [J]. LANCET, 1997, 350 (9090) : 1495 - 1499
  • [10] Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis
    Azoulay, D
    Castaing, D
    Majno, P
    Saliba, F
    Ichaï, P
    Smail, A
    Delvart, V
    Danaoui, M
    Samuel, D
    Bismuth, H
    [J]. JOURNAL OF HEPATOLOGY, 2001, 35 (05) : 590 - 597